Global Pain Management Drugs Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Description

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at US$ 38850 million in 2024 and is forecast to a readjusted size of USD 48390 million by 2031 with a CAGR of 3.2% during review period.

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.

This report is a detailed and comprehensive analysis for global Pain Management Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Pain Management Drugs market size and forecasts, in consumption value ($ Million), 2020-2031
Global Pain Management Drugs market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Pain Management Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Pain Management Drugs market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pain Management Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pain Management Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Pfizer, Grunenthal, Sanofi, Bayer, AstraZeneca, Eli Lilly, Endo, Merck, Yunnan Baiyao, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Pain Management Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Generic Opioids
    Branded Opioids
    NSAIDs
    Others

Market segment by Application
    Hospitals
    Drugstores
    Others

Market segment by players, this report covers
    GSK
    Pfizer
    Grunenthal
    Sanofi
    Bayer
    AstraZeneca
    Eli Lilly
    Endo
    Merck
    Yunnan Baiyao
    Teikoku Seiyaku
    Teva
    J&J
    Assertio Therapeutics
    Allergan

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pain Management Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pain Management Drugs, with revenue, gross margin, and global market share of Pain Management Drugs from 2020 to 2025.
Chapter 3, the Pain Management Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Pain Management Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pain Management Drugs.
Chapter 13, to describe Pain Management Drugs research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Pain Management Drugs by Type
        1.3.1 Overview: Global Pain Management Drugs Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global Pain Management Drugs Consumption Value Market Share by Type in 2024
        1.3.3 Generic Opioids
        1.3.4 Branded Opioids
        1.3.5 NSAIDs
        1.3.6 Others
    1.4 Global Pain Management Drugs Market by Application
        1.4.1 Overview: Global Pain Management Drugs Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Hospitals
        1.4.3 Drugstores
        1.4.4 Others
    1.5 Global Pain Management Drugs Market Size & Forecast
    1.6 Global Pain Management Drugs Market Size and Forecast by Region
        1.6.1 Global Pain Management Drugs Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global Pain Management Drugs Market Size by Region, (2020-2031)
        1.6.3 North America Pain Management Drugs Market Size and Prospect (2020-2031)
        1.6.4 Europe Pain Management Drugs Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific Pain Management Drugs Market Size and Prospect (2020-2031)
        1.6.6 South America Pain Management Drugs Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa Pain Management Drugs Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 GSK
        2.1.1 GSK Details
        2.1.2 GSK Major Business
        2.1.3 GSK Pain Management Drugs Product and Solutions
        2.1.4 GSK Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 GSK Recent Developments and Future Plans
    2.2 Pfizer
        2.2.1 Pfizer Details
        2.2.2 Pfizer Major Business
        2.2.3 Pfizer Pain Management Drugs Product and Solutions
        2.2.4 Pfizer Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Pfizer Recent Developments and Future Plans
    2.3 Grunenthal
        2.3.1 Grunenthal Details
        2.3.2 Grunenthal Major Business
        2.3.3 Grunenthal Pain Management Drugs Product and Solutions
        2.3.4 Grunenthal Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Grunenthal Recent Developments and Future Plans
    2.4 Sanofi
        2.4.1 Sanofi Details
        2.4.2 Sanofi Major Business
        2.4.3 Sanofi Pain Management Drugs Product and Solutions
        2.4.4 Sanofi Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 Sanofi Recent Developments and Future Plans
    2.5 Bayer
        2.5.1 Bayer Details
        2.5.2 Bayer Major Business
        2.5.3 Bayer Pain Management Drugs Product and Solutions
        2.5.4 Bayer Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Bayer Recent Developments and Future Plans
    2.6 AstraZeneca
        2.6.1 AstraZeneca Details
        2.6.2 AstraZeneca Major Business
        2.6.3 AstraZeneca Pain Management Drugs Product and Solutions
        2.6.4 AstraZeneca Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 AstraZeneca Recent Developments and Future Plans
    2.7 Eli Lilly
        2.7.1 Eli Lilly Details
        2.7.2 Eli Lilly Major Business
        2.7.3 Eli Lilly Pain Management Drugs Product and Solutions
        2.7.4 Eli Lilly Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.7.5 Eli Lilly Recent Developments and Future Plans
    2.8 Endo
        2.8.1 Endo Details
        2.8.2 Endo Major Business
        2.8.3 Endo Pain Management Drugs Product and Solutions
        2.8.4 Endo Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.8.5 Endo Recent Developments and Future Plans
    2.9 Merck
        2.9.1 Merck Details
        2.9.2 Merck Major Business
        2.9.3 Merck Pain Management Drugs Product and Solutions
        2.9.4 Merck Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.9.5 Merck Recent Developments and Future Plans
    2.10 Yunnan Baiyao
        2.10.1 Yunnan Baiyao Details
        2.10.2 Yunnan Baiyao Major Business
        2.10.3 Yunnan Baiyao Pain Management Drugs Product and Solutions
        2.10.4 Yunnan Baiyao Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.10.5 Yunnan Baiyao Recent Developments and Future Plans
    2.11 Teikoku Seiyaku
        2.11.1 Teikoku Seiyaku Details
        2.11.2 Teikoku Seiyaku Major Business
        2.11.3 Teikoku Seiyaku Pain Management Drugs Product and Solutions
        2.11.4 Teikoku Seiyaku Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.11.5 Teikoku Seiyaku Recent Developments and Future Plans
    2.12 Teva
        2.12.1 Teva Details
        2.12.2 Teva Major Business
        2.12.3 Teva Pain Management Drugs Product and Solutions
        2.12.4 Teva Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.12.5 Teva Recent Developments and Future Plans
    2.13 J&J
        2.13.1 J&J Details
        2.13.2 J&J Major Business
        2.13.3 J&J Pain Management Drugs Product and Solutions
        2.13.4 J&J Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.13.5 J&J Recent Developments and Future Plans
    2.14 Assertio Therapeutics
        2.14.1 Assertio Therapeutics Details
        2.14.2 Assertio Therapeutics Major Business
        2.14.3 Assertio Therapeutics Pain Management Drugs Product and Solutions
        2.14.4 Assertio Therapeutics Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.14.5 Assertio Therapeutics Recent Developments and Future Plans
    2.15 Allergan
        2.15.1 Allergan Details
        2.15.2 Allergan Major Business
        2.15.3 Allergan Pain Management Drugs Product and Solutions
        2.15.4 Allergan Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.15.5 Allergan Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Pain Management Drugs Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of Pain Management Drugs by Company Revenue
        3.2.2 Top 3 Pain Management Drugs Players Market Share in 2024
        3.2.3 Top 6 Pain Management Drugs Players Market Share in 2024
    3.3 Pain Management Drugs Market: Overall Company Footprint Analysis
        3.3.1 Pain Management Drugs Market: Region Footprint
        3.3.2 Pain Management Drugs Market: Company Product Type Footprint
        3.3.3 Pain Management Drugs Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Pain Management Drugs Consumption Value and Market Share by Type (2020-2025)
    4.2 Global Pain Management Drugs Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global Pain Management Drugs Consumption Value Market Share by Application (2020-2025)
    5.2 Global Pain Management Drugs Market Forecast by Application (2026-2031)

6 North America
    6.1 North America Pain Management Drugs Consumption Value by Type (2020-2031)
    6.2 North America Pain Management Drugs Market Size by Application (2020-2031)
    6.3 North America Pain Management Drugs Market Size by Country
        6.3.1 North America Pain Management Drugs Consumption Value by Country (2020-2031)
        6.3.2 United States Pain Management Drugs Market Size and Forecast (2020-2031)
        6.3.3 Canada Pain Management Drugs Market Size and Forecast (2020-2031)
        6.3.4 Mexico Pain Management Drugs Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe Pain Management Drugs Consumption Value by Type (2020-2031)
    7.2 Europe Pain Management Drugs Consumption Value by Application (2020-2031)
    7.3 Europe Pain Management Drugs Market Size by Country
        7.3.1 Europe Pain Management Drugs Consumption Value by Country (2020-2031)
        7.3.2 Germany Pain Management Drugs Market Size and Forecast (2020-2031)
        7.3.3 France Pain Management Drugs Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom Pain Management Drugs Market Size and Forecast (2020-2031)
        7.3.5 Russia Pain Management Drugs Market Size and Forecast (2020-2031)
        7.3.6 Italy Pain Management Drugs Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific Pain Management Drugs Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific Pain Management Drugs Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific Pain Management Drugs Market Size by Region
        8.3.1 Asia-Pacific Pain Management Drugs Consumption Value by Region (2020-2031)
        8.3.2 China Pain Management Drugs Market Size and Forecast (2020-2031)
        8.3.3 Japan Pain Management Drugs Market Size and Forecast (2020-2031)
        8.3.4 South Korea Pain Management Drugs Market Size and Forecast (2020-2031)
        8.3.5 India Pain Management Drugs Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia Pain Management Drugs Market Size and Forecast (2020-2031)
        8.3.7 Australia Pain Management Drugs Market Size and Forecast (2020-2031)

9 South America
    9.1 South America Pain Management Drugs Consumption Value by Type (2020-2031)
    9.2 South America Pain Management Drugs Consumption Value by Application (2020-2031)
    9.3 South America Pain Management Drugs Market Size by Country
        9.3.1 South America Pain Management Drugs Consumption Value by Country (2020-2031)
        9.3.2 Brazil Pain Management Drugs Market Size and Forecast (2020-2031)
        9.3.3 Argentina Pain Management Drugs Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa Pain Management Drugs Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa Pain Management Drugs Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa Pain Management Drugs Market Size by Country
        10.3.1 Middle East & Africa Pain Management Drugs Consumption Value by Country (2020-2031)
        10.3.2 Turkey Pain Management Drugs Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia Pain Management Drugs Market Size and Forecast (2020-2031)
        10.3.4 UAE Pain Management Drugs Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 Pain Management Drugs Market Drivers
    11.2 Pain Management Drugs Market Restraints
    11.3 Pain Management Drugs Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Pain Management Drugs Industry Chain
    12.2 Pain Management Drugs Upstream Analysis
    12.3 Pain Management Drugs Midstream Analysis
    12.4 Pain Management Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Pain Management Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Pain Management Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global Pain Management Drugs Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global Pain Management Drugs Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. GSK Company Information, Head Office, and Major Competitors
 Table 6. GSK Major Business
 Table 7. GSK Pain Management Drugs Product and Solutions
 Table 8. GSK Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. GSK Recent Developments and Future Plans
 Table 10. Pfizer Company Information, Head Office, and Major Competitors
 Table 11. Pfizer Major Business
 Table 12. Pfizer Pain Management Drugs Product and Solutions
 Table 13. Pfizer Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. Pfizer Recent Developments and Future Plans
 Table 15. Grunenthal Company Information, Head Office, and Major Competitors
 Table 16. Grunenthal Major Business
 Table 17. Grunenthal Pain Management Drugs Product and Solutions
 Table 18. Grunenthal Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. Sanofi Company Information, Head Office, and Major Competitors
 Table 20. Sanofi Major Business
 Table 21. Sanofi Pain Management Drugs Product and Solutions
 Table 22. Sanofi Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 23. Sanofi Recent Developments and Future Plans
 Table 24. Bayer Company Information, Head Office, and Major Competitors
 Table 25. Bayer Major Business
 Table 26. Bayer Pain Management Drugs Product and Solutions
 Table 27. Bayer Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 28. Bayer Recent Developments and Future Plans
 Table 29. AstraZeneca Company Information, Head Office, and Major Competitors
 Table 30. AstraZeneca Major Business
 Table 31. AstraZeneca Pain Management Drugs Product and Solutions
 Table 32. AstraZeneca Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 33. AstraZeneca Recent Developments and Future Plans
 Table 34. Eli Lilly Company Information, Head Office, and Major Competitors
 Table 35. Eli Lilly Major Business
 Table 36. Eli Lilly Pain Management Drugs Product and Solutions
 Table 37. Eli Lilly Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 38. Eli Lilly Recent Developments and Future Plans
 Table 39. Endo Company Information, Head Office, and Major Competitors
 Table 40. Endo Major Business
 Table 41. Endo Pain Management Drugs Product and Solutions
 Table 42. Endo Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 43. Endo Recent Developments and Future Plans
 Table 44. Merck Company Information, Head Office, and Major Competitors
 Table 45. Merck Major Business
 Table 46. Merck Pain Management Drugs Product and Solutions
 Table 47. Merck Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 48. Merck Recent Developments and Future Plans
 Table 49. Yunnan Baiyao Company Information, Head Office, and Major Competitors
 Table 50. Yunnan Baiyao Major Business
 Table 51. Yunnan Baiyao Pain Management Drugs Product and Solutions
 Table 52. Yunnan Baiyao Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 53. Yunnan Baiyao Recent Developments and Future Plans
 Table 54. Teikoku Seiyaku Company Information, Head Office, and Major Competitors
 Table 55. Teikoku Seiyaku Major Business
 Table 56. Teikoku Seiyaku Pain Management Drugs Product and Solutions
 Table 57. Teikoku Seiyaku Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 58. Teikoku Seiyaku Recent Developments and Future Plans
 Table 59. Teva Company Information, Head Office, and Major Competitors
 Table 60. Teva Major Business
 Table 61. Teva Pain Management Drugs Product and Solutions
 Table 62. Teva Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 63. Teva Recent Developments and Future Plans
 Table 64. J&J Company Information, Head Office, and Major Competitors
 Table 65. J&J Major Business
 Table 66. J&J Pain Management Drugs Product and Solutions
 Table 67. J&J Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 68. J&J Recent Developments and Future Plans
 Table 69. Assertio Therapeutics Company Information, Head Office, and Major Competitors
 Table 70. Assertio Therapeutics Major Business
 Table 71. Assertio Therapeutics Pain Management Drugs Product and Solutions
 Table 72. Assertio Therapeutics Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 73. Assertio Therapeutics Recent Developments and Future Plans
 Table 74. Allergan Company Information, Head Office, and Major Competitors
 Table 75. Allergan Major Business
 Table 76. Allergan Pain Management Drugs Product and Solutions
 Table 77. Allergan Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 78. Allergan Recent Developments and Future Plans
 Table 79. Global Pain Management Drugs Revenue (USD Million) by Players (2020-2025)
 Table 80. Global Pain Management Drugs Revenue Share by Players (2020-2025)
 Table 81. Breakdown of Pain Management Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 82. Market Position of Players in Pain Management Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 83. Head Office of Key Pain Management Drugs Players
 Table 84. Pain Management Drugs Market: Company Product Type Footprint
 Table 85. Pain Management Drugs Market: Company Product Application Footprint
 Table 86. Pain Management Drugs New Market Entrants and Barriers to Market Entry
 Table 87. Pain Management Drugs Mergers, Acquisition, Agreements, and Collaborations
 Table 88. Global Pain Management Drugs Consumption Value (USD Million) by Type (2020-2025)
 Table 89. Global Pain Management Drugs Consumption Value Share by Type (2020-2025)
 Table 90. Global Pain Management Drugs Consumption Value Forecast by Type (2026-2031)
 Table 91. Global Pain Management Drugs Consumption Value by Application (2020-2025)
 Table 92. Global Pain Management Drugs Consumption Value Forecast by Application (2026-2031)
 Table 93. North America Pain Management Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 94. North America Pain Management Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 95. North America Pain Management Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 96. North America Pain Management Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 97. North America Pain Management Drugs Consumption Value by Country (2020-2025) & (USD Million)
 Table 98. North America Pain Management Drugs Consumption Value by Country (2026-2031) & (USD Million)
 Table 99. Europe Pain Management Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 100. Europe Pain Management Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 101. Europe Pain Management Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 102. Europe Pain Management Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 103. Europe Pain Management Drugs Consumption Value by Country (2020-2025) & (USD Million)
 Table 104. Europe Pain Management Drugs Consumption Value by Country (2026-2031) & (USD Million)
 Table 105. Asia-Pacific Pain Management Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 106. Asia-Pacific Pain Management Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 107. Asia-Pacific Pain Management Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 108. Asia-Pacific Pain Management Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 109. Asia-Pacific Pain Management Drugs Consumption Value by Region (2020-2025) & (USD Million)
 Table 110. Asia-Pacific Pain Management Drugs Consumption Value by Region (2026-2031) & (USD Million)
 Table 111. South America Pain Management Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 112. South America Pain Management Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 113. South America Pain Management Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 114. South America Pain Management Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 115. South America Pain Management Drugs Consumption Value by Country (2020-2025) & (USD Million)
 Table 116. South America Pain Management Drugs Consumption Value by Country (2026-2031) & (USD Million)
 Table 117. Middle East & Africa Pain Management Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 118. Middle East & Africa Pain Management Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 119. Middle East & Africa Pain Management Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 120. Middle East & Africa Pain Management Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 121. Middle East & Africa Pain Management Drugs Consumption Value by Country (2020-2025) & (USD Million)
 Table 122. Middle East & Africa Pain Management Drugs Consumption Value by Country (2026-2031) & (USD Million)
 Table 123. Global Key Players of Pain Management Drugs Upstream (Raw Materials)
 Table 124. Global Pain Management Drugs Typical Customers


List of Figures
 Figure 1. Pain Management Drugs Picture
 Figure 2. Global Pain Management Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Pain Management Drugs Consumption Value Market Share by Type in 2024
 Figure 4. Generic Opioids
 Figure 5. Branded Opioids
 Figure 6. NSAIDs
 Figure 7. Others
 Figure 8. Global Pain Management Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 9. Pain Management Drugs Consumption Value Market Share by Application in 2024
 Figure 10. Hospitals Picture
 Figure 11. Drugstores Picture
 Figure 12. Others Picture
 Figure 13. Global Pain Management Drugs Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 14. Global Pain Management Drugs Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 15. Global Market Pain Management Drugs Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 16. Global Pain Management Drugs Consumption Value Market Share by Region (2020-2031)
 Figure 17. Global Pain Management Drugs Consumption Value Market Share by Region in 2024
 Figure 18. North America Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 19. Europe Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 20. Asia-Pacific Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 21. South America Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 22. Middle East & Africa Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 23. Company Three Recent Developments and Future Plans
 Figure 24. Global Pain Management Drugs Revenue Share by Players in 2024
 Figure 25. Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 26. Market Share of Pain Management Drugs by Player Revenue in 2024
 Figure 27. Top 3 Pain Management Drugs Players Market Share in 2024
 Figure 28. Top 6 Pain Management Drugs Players Market Share in 2024
 Figure 29. Global Pain Management Drugs Consumption Value Share by Type (2020-2025)
 Figure 30. Global Pain Management Drugs Market Share Forecast by Type (2026-2031)
 Figure 31. Global Pain Management Drugs Consumption Value Share by Application (2020-2025)
 Figure 32. Global Pain Management Drugs Market Share Forecast by Application (2026-2031)
 Figure 33. North America Pain Management Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 34. North America Pain Management Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 35. North America Pain Management Drugs Consumption Value Market Share by Country (2020-2031)
 Figure 36. United States Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 37. Canada Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 38. Mexico Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 39. Europe Pain Management Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 40. Europe Pain Management Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 41. Europe Pain Management Drugs Consumption Value Market Share by Country (2020-2031)
 Figure 42. Germany Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 43. France Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 44. United Kingdom Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 45. Russia Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 46. Italy Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 47. Asia-Pacific Pain Management Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 48. Asia-Pacific Pain Management Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 49. Asia-Pacific Pain Management Drugs Consumption Value Market Share by Region (2020-2031)
 Figure 50. China Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 51. Japan Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 52. South Korea Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 53. India Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 54. Southeast Asia Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 55. Australia Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 56. South America Pain Management Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 57. South America Pain Management Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 58. South America Pain Management Drugs Consumption Value Market Share by Country (2020-2031)
 Figure 59. Brazil Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 60. Argentina Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 61. Middle East & Africa Pain Management Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 62. Middle East & Africa Pain Management Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 63. Middle East & Africa Pain Management Drugs Consumption Value Market Share by Country (2020-2031)
 Figure 64. Turkey Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 65. Saudi Arabia Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 66. UAE Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 67. Pain Management Drugs Market Drivers
 Figure 68. Pain Management Drugs Market Restraints
 Figure 69. Pain Management Drugs Market Trends
 Figure 70. Porters Five Forces Analysis
 Figure 71. Pain Management Drugs Industrial Chain
 Figure 72. Methodology
 Figure 73. Research Process and Data Source

Companies Mentioned

GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan